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Abstract 
The purpose of this study was to identify sites where striatopallidal lesions produce two distinct sensory-triggered hyperkinetic 
syndromes: (1) exaggerated forelimb treading alone to oral taste infusions and (2) sensorimotor exaggerated treading plus 
enhanced aversive reactions to taste infusions. The behavioral characteristics of these syndromes have been described previously 
(Berridge, K.C. and Cromwell, H.C., Behav. Neurosci., 104 (1990) 778-795). Bilateral excitotoxin lesions were made using 
quinolinic acid (10 /zg in 1 p.1) in the caudate/putamen, nucleus accumbens, globus pallidus or ventral pallidum/substantia 
innominata. In order to identify the precise center, borders, severity and size of lesion sites that caused these hyperkinetic 
treading syndromes, neuron counts (modified fractionator technique) and glial fibrillary acidic protein immunoreactivity 
(GFAP-IR) densitometry were used in a stereological mapping analysis. The site of lesions that produced the hyperkinetic 
treading syndrome without enhanced aversion was found to be restricted to the globus pallidus (GP). Damage exceeding 60% 
neuron loss bilaterally within a 0.8 x 1.0 x 1.0 mm subregion of the ventromedial GP produced this syndrome. The site of lesions 
that produced the combined syndrome of hyperkinetic treading and aversive enhancement was ventral to the globus pallidus, 
within the ventral pallidum/substantia innominata (VP/SI). Damage exceeding 70% neuron loss bilaterally within a 1.0 x 0.5 x 
1.0 mm diameter subregion of the ventromedial ventral pallidum/substantia innominata produced this syndrome. This 
subterritory was located immediately lateral to the border of the lateral hypothalamus. Bilateral lesions to the caudate/putamen 
or nucleus accumbens did not produce either hyperkinetic treading syndrome. These results are discussed in terms of the 
connectivity of the ventral pallidal/substantia innominata and globus pallidus regions and in terms of neuropathological models 
of hyperkinetic disorders. 
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1. Introduction 
Hyperkinetic movements of Huntington's  disease 
[73], Gilles de la Touret te ' s  syndrome, and tardive 
dyskinesia are thought to originate from disturbances 
in neuronal activity of the striatopallidal system 
[1,6,25,68,75]. Pathological movements  of these disor- 
ders can range from brief, simple motor  tics (defined as 
"stereotyped jerks of isolated muscles of the upper  
parts of the body"; see Thompson et al. [71] p. 214) to 
choreiform sequences (defined as "brisk, graceful se- 
ries of  successive, involuntary movements  of consider- 
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able complexity which resemble fragments of purpose- 
ful voluntary movements";  see Carpenter  [17] p. 253). 
Examples of the former include an abrupt shrug of the 
shoulder or rapid forearm extension while the latter 
could involve a combination of forelimb reaches inter- 
twined with finger flexion or hand grasping motions. 
Most animal models of hyperkinesia only partially 
replicate the characteristics of any of these disorders. 
In humans, hyperkinetic movements  are often sponta- 
neous after damage to particular brain regions, yet in 
many animal models hyperkinetic movements  appear  
only after the administration of drugs. For example, 
Crossman and colleagues have produced hyperkinetic 
movements in the monkey by injecting bicuculline, a 
G A B A  receptor antagonist, into the lateral globus pal- 
lidus [20,42]. Movements analogous to chorea are seen 
in monkeys given levodopa or apomorphine after stri- 
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atal lesions [37,44]. In the rat, chronic systemic injec- 
tions of 3,3-iminodipropionitrile, a neurotoxin, have 
produced choreiform and athetoid head and neck 
movements [67], and intracaudate injections of a GABA 
antagonist combined with sensorimotor cortex damage 
have produced rhythmic jerking of the limbs [70]. In a 
few studies of non-human primates, spontaneous hy- 
perkinesia without drug administration has been pro- 
duced. Denny-Brown reported a 'wing-beating' motion 
in monkeys with putamen lesions [22], and Carpenter 
has reported hyperkinetic movements following bilat- 
eral pallidal damage in the macaque monkey [16] 
Recently, a novel hyperkinetic movement pattern 
has been documented in the rat, which occurs after 
striatopallidal lesions [11]. This hyperkinetic movement 
pattern is perhaps the first to be reported for rodents 
that occurs without need of pharmacological manipula- 
tion. The movement pattern resembles both the hyper- 
kinetic movements of Huntington's disease and of 
Tourette's syndrome in several respects [10,11]. In the 
rat, the hyperkinetic movement is triggered by oral 
sensory input not unlike the sensory-triggered motor 
tics observed in certain cases of Tourette's syndrome 
[14,46]. The hyperkinetic movement in rats is an exag- 
gerated paw treading: a rapid, vigorous and rhythmic 
forelimb extension followed by retraction. Hyperkinetic 
treading is an exaggeration of normal but infrequent 
paw treading seen in intact rats in response to oral 
infusions of highly bitter-tasting solutions. Normal 
paw-treading described by Grill and Norgren [26] is 
composed of smaller forelimb movements ranging in 
amplitude from 1-5 mm and lasting as a series of 
movements typically 1-5 s. 
The pathological exaggeration of treading produced 
by striatopallidal lesions is manifest by an increase in 
incidence, amplitude, and duration of the movement 
pattern compared to normal rats. After large excito- 
toxin lesions of the posterior corpus striatum and palli- 
dal region, 100% of rats show exaggerated treading to 
oral infusions of quinine (as opposed to only 10% of 
normal rats that show ordinary treading). The ampli- 
tude of the movements is increased 5 to 10 times 
(ranging from 1 cm to 3 cm in each cycle for the 
hyperkinetic form) and the duration of a bout is in- 
creased 3 to 10 times (ranging from 12 to 60 s of a 1 
min trial) [10,11]. 
A peculiar feature of some hyperkinetic disorders in 
humans is that the emotional state of the patient may 
affect the expression of the hyperkinetic movement 
produced by the disease [15]. For example, choreic 
movements become more frequent and greater in am- 
plitude upon increased arousal or stress [45]. When a 
psychological 'load' is added to a motor task for pa- 
tients with choreiform disorder, the choreic movements 
become more pronounced compared to the choreic 
movements seen in the same motor task ordinarily [57]. 
Hyperkinetic treading by the rat with a large striatopal- 
lidal lesion is similar in that it also is regulated by 
emotional state. In particular it is enhanced by certain 
aversive states. For example, some rats with large le- 
sions of the striatopallidal system display the hyperki- 
netic treading to only bitter 'aversive' tasting solutions 
and not sweet 'palatable' tasting solutions. These rats 
can be converted to show the hyperkinetic treading to 
sweet 'palatable' tastes by associatively pairing these 
sweet solutions (sucrose)with LiCl-induced illness [11]. 
This result suggests that motivational aversion and 
sensorimotor pathology interact to control the final 
expression of pathological treading by rats after stri- 
atopallidal damage [11,19]. 
Hyperkinetic treading in the rat can occur in two 
distinct forms or syndromes after striatopallidal lesions 
depending apparently on properties of the lesion such 
as location, size or severity of neuron loss [11]. In the 
first syndrome (treading only or 'T syndrome'), rats 
emit hyperkinetic treading only to bitter or other un- 
palatable tastes, and are essentially normal in locomo- 
tion and feeding behavior. In the second syndrome 
(enhanced aversion plus treading or 'A + T syndrome'), 
rats emit hyperkinetic treading to all tastes and show 
aversive reactions (e.g. gapes, head-shakes, chin-rubs, 
and forelimb-flails) to all tastes, even to normally 
palatable sucrose. The exact location and boundary of 
the striatopallidal site or sites where damage produces 
hyperkinetic treading has not previously been identi- 
fied. Nor has it been shown how the two syndromes 
differ in terms of their neural damage. The present 
study was conducted in order to identify the crucial 
properties of the lesion that determine which syn- 
drome is produced. Procedures were employed to mea- 
sure the size, severity, and the neuroanatomical bound- 
aries of the sites for the two syndromes. A novel 
neuron counting technique, a modification of Gunder- 
sen et al.'s 'fractionator' procedure [33] and immuno- 
cytochemical staining for glial fibrillary acidic protein 
were used to precisely identify these lesion sites. 
2. Materials and methods 
2.1. Subjects 
Subjects were 47 male and 56 female Sprague-Daw- 
ley rats (Charles-River) weighing 300 + 50 g at the 
beginning of the experiment. They were housed singly 
under a 12:12 light:dark cycle. Water and food were 
freely available. 
2.2. Surgery 
Rats were anesthetized using first halothane (within 
a desiccator chamber) and then methoxy-fluorane given 
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through an air anesthesia system for small animals [49]. 
Atropine sulfate (3 m g / kg ,  i.p.) and diazepam (8 
mg /kg )  were given approximately 30 min prior to 
neurotoxin injection. Bilateral lesions were made using 
quinolinic acid (10 # g  in 1 Izl). This neurotoxin has 
been suggested to play a role in the natural production 
of certain hyperkinetic disorders such as Huntington's  
disease in humans [13]. Most lesions were focused on 
posterior and ventral striatopallidal structures, since 
previous studies have indicated that lesions of these 
structures may have a special role in exaggerated tread- 
ing [11,19]. Lesions intended to damage the ventral 
striatum or nucleus accumbens were centered at the 
coordinates: AP + 1.7 mm anterior to bregma; L + 1.5 
mm lateral to bregma; V - 7 . 4  mm below the skull 
(n = 8 rats). Lesions intended to damage the neostria- 
turn or caudate nucleus and putamen (CPU) were 
aimed into four different quadrants. These included 
the dorsolateral quadrant: AP + 1.0 mm; L + 3.7 mm; 
and V - 4 . 5  mm (n = 8 rats), the dorsomedial quad- 
rant: AP + 1.0 mm; L + 1.6 mm; V - 4.2 mm (n = 8), 
the ventromedial quadrant: AP + 1.0 mm; L + 1.7 mm; 
V - 5 . 6  mm (n = 4) or the ventrolateral quadrant: AP 
+ 1.0 mm; L +3.6 mm; V - 6 . 6  mm (n = 8). Lesions 
intended to damage the globus pallidus were centered 
at the coordinates: AP - 1.0 mm; L + 2.8 mm; V - 7.5 
mm (n = 13 rats). Lesions intended to damage the 
ventral pal l idum/substant ia  innominata were centered 
at the coordinates: AP - 1.0 mm; L + 2.5 ram; V - 8.0 
mm (n = 10). The actual center of the lesions varied 
around these coordinates. The vehicle solution was 
always phosphate buffered saline (pH = 7.4). Sham op- 
erated controls received infusions of PBS alone (1 /~1, 
nucleus accumbens, n = 8, CPU, n = 28, pal l idal /SI ,  
n = 8). Each infusion was made over a 3 min period, 
and the needle was left in place for an additional 5 
min. 
Each rat was implanted with bilateral chronic oral 
cannulae to allow for the infusion of the taste solutions 
into the mouth. These cannulae (heat-flared PE-50 
tubing) [27] enter the mouth lateral to the first maxil- 
lary molar and exit the head near the dorsolateral 
boundary of the skull, where they are anchored with 
skull screws and acrylic cement. 
Thirty min post-surgery, a second injection of di- 
azepam (8 m g / k g )  was given to reduce potential con- 
vulsive activity. Bicillin (30,000 units, i.m.) was given to 
reduce the chances of post-surgical infection. All rats 
were given 250 ml of cereal mash (commercial baby 
cereal mixed with water), 5 chow pellets and 40 ml of 
water per day (5-7 p.m. feeding). Aphagia and adipsia 
may follow striatopallidal neurotoxin injections [50]. 
Intake was monitored by counting the number  of pel- 
lets consumed, the approximate amount of mash eaten 
(e.g. 50%), and the amount of water drank within a 
24-h period. Rats were weighed daily. If  a rat lost 
weight compared to his pre-surgical weight, then an 
intubation procedure was initiated. For each 5 g of 
weight lost, the rat was intubated with 12 ml of vitamin 
supplemented sweetened milk solution, up to 3 intuba- 
tions per day. Rats were considered aphagic if neither 
chow nor pellets were eaten. 
2.3. Behavioral observations 
Sensory-triggered hyperkinetic treading and other 
taste reactions were videotaped, after an initial habitu- 
ation trial, to oral infusions of sucrose (1 M) or quinine 
HCL (3 × 10 -4) in counterbalanced order. Sucrose 
elicits primarily ingestive responses and quinine elicits 
primarily aversive responses from normal rats. The 
initial trial (48 h post-surgery) used distilled water oral 
infusions for habituation. 
A delivery tube was connected to the oral cannula, 
and the rat was placed in a t ransparent  test chamber,  
which was suspended over an angled mirror. The mir- 
ror reflected a view of the rat 's mouth and forepaws to 
the videocamera. Following a 5 min habituation period, 
1 ml of the test solution was infused directly into the 
mouth over a 1 min period. If multiple stimuli were 
given in a single day, there was a two hour inter-test 
interval. Tests were run between 4 and 8 p.m. (i.e. 
shortly prior to lights out). For aphagic rats receiving 
intubations, taste trials were conducted at least 2 h 
after the last intubation. 
2.4. Taste reactivity scoring 
Videotapes were scored in slow motion (frame by 
frame to 1 /10  normal speed) for the occurrence of 
exaggerated paw treading. A stringent criterion was 
used for the analysis of paw treading in order to avoid 
'false positive' scoring of normal treading and ensure 
that only pathological exaggerated paw treading would 
be included. A unit of paw treading was required to be 
at least 5 continuous seconds of rhythmic forward and 
backward extension of the forepaws 180 ° out of phase, 
with the two paws extended at least 1 cm apart  in every 
cycle, at a frequency of roughly 3.5 Hz. 
Videotapes were also scored for the occurrence of 
aversive reactions and for positive hedonic reactions. 
Aversive actions include: gapes: large openings of the 
mouth and jaw lasting approximately 125 ms; chin-rub- 
bing: bringing the chin in direct contact with the floor 
and projecting the body forward; face-washing: either a 
single wipe with the paws over the face or a bout of 
several wipes; forelimb flails: shaking of the forelimb 
back and forth; and rapid head-shaking. Paw treading 
was specifically excluded from the aversive scores to 
reduce artificial aversive score inflation. 
H.C. Cromwell, K.C. Berridge / Brain Research 668 (1994) 16-29 19 
The  following positive react ions were scored: lateral  
tongue  prot rus ions  (nonrhythmic)  lasting about  160 ms; 
rhythmic tongue  protrusions:  these p ro t rude  along the 
rnidline with a cycle length  of roughly 160 ms; and  
paw-licking. Each act ion was scored and  counted  using 
cri teria described in Gril l  and Norgren  [26]. 
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Fig. 1. Fraction zones. The 251 fraction zones used for the fractionator technique. Each fraction is labeled by its assigned number. Smaller 
fractions are positioned around the excitotoxin microinjection targets. Lower left: example of lesion boundary analysis along 8 radial arms from 
the center of a lesion. Neuron counts were continued along each arm until either the boundary of the lesion edge or the circumference was 
reached (2.5 mm from center, whichever came first. 
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2.5. Histology 
At the conclusion of the behavioral testing, each rat 
was deeply anesthetized and intracardially perfused. 
Perfusions were completed with 0.9% saline followed 
by 10% formalin in PBS (pH = 7.4). Brains were re- 
moved and stored in a 30% sucrose solution (10% 
formalin). The brains were blocked, frozen, and sliced 
into 30 /~m slices using a sliding microtome. Slices 
were mounted directly onto gelatin-coated slides for 
Cresyl violet staining. The slides were dipped in xylene 
and ethanol baths (70%, 95% and 100%) for cleaning 
and defatting. After being dipped in Cresyl violet, the 
slides were taken through the final alcohols and xylenes 
prior to coverslipping using permount. A modification 
of Gundersen's fractionator technique for obtaining 
accurate regional counts of neurons was completed in 
order to specify the exact borders and intensity of 
damage within this general region. 
2.6. Approximate localization of damage 
An initial examination of each brain was made at 5 
anterior-posterior  levels (Bregma + 1.7 mm, + 0.7 mm, 
- 0 . 3  mm, - 1 . 3  mm, and -2 .3  mm) in order to 
identify the approximate location of lesions in the 
neostriatum, globus pallidus, ventral pallidum or sub- 
stantia innominata. Neuron counts were made using a 
light microscope (Leitz Laborlux S), a videocamera and 
a computerized videoimage analysis system (JAVA, 
Jandel) in nine regions at each level. The videoimage 
analysis system was used to project an image of the 
slice upon a monitor and exactly delineate the borders 
of the particular regions within the striatopallidal sys- 
tem. This technique led to a high consistency in terms 
of the region shapes and positions between the differ- 
ent rat brain slices. To determine the neuronal density 
within striatopallidal regions, neuron cell counts were 
completed using a eyepiece reticule (10 mm by 10 mm 
divided into 1.0 mm squares) placed into a 10 x eye- 
piece. The light microscope analysis was completed 
using a 20 X objective (total magnification 200 x ). A 
neuron was defined for scoring purposes as an intact 
circular or ovoid shaped object with a light purple 
interior stain, at least 10 microns in diameter (one-fifth 
of a 50 micron length individual grid). Both medium 
(10-15 microns in diameter) and large (>  15 microns 
in diameter) neurons were counted. The nucleus was 
not required to be present in order for an object to be 
counted as a neuron. 
2. 7. Fractionator analysis of  lesion boundaries 
Identified lesions were analyzed in detail using our 
modification [19] of the fractionator technique [33]. 
Twenty-five rats were selected for the modified frac- 
tionator technique (8 controls, 17 hyperkinetic paw 
treaders). This procedure was conducted in 3 stages. 
Stage 1. Normal reference maps. First, in order to 
obtain accurate normal baseline neuron averages, the 
normal neuronal density of 251 brain fractions from 7 
AP levels was determined using a modification of Gun- 
dersen's fractionator technique [33] (see Fig. 1). Frac- 
tions ranged in cubic volume from 0.03 mm 3 to 0.375 
mm 3. The smallest fractions were grouped around sites 
of injections. For a complete listing of the normal 
neuron density for all fractions (n = 251) of the stri- 
atopallidal system see Table 1. 
For each fraction, an exhaustive neuronal count was 
made of a 250 × 250 × 30 micron 'core sample'. This 
was done by delineating a 250 square micron area of a 
30 micron tissue section (randomly chosen within each 
fraction) at 400 x magnification using the videoimage 
analysis system. Neurons were counted throughout the 
total volume of the fraction by counting all neurons at 
each plane of focus. Neuronal density varied from 
fraction to fraction in normal animals from 12 neurons 
in fractions from the globus pallidus to 154 neurons in 
fractions from the ventrolateral striatum. However, 
neuronal density varied by less than 25% between 
different rats for any given fraction. This consistency 
between animals in neuronal density for a given frac- 
tion allowed us to set a criterion for the detection of 
lesions. 
Stage 2a. Identifying lesions by the fractionator 
method. 'Moderate  neuron loss' was judged to exist if a 
fraction had less than 50% of the normal mean number 
of neurons for that fraction. Since normal brains vary 
by less than 25%, a neuronal density decrease below 
50% falls well beyond the normal range. Areas that 
had greater than 50% neuron loss but less than 80% 
neuron loss were labeled as the shell of the lesion. 
'Severe neuron loss' existed if the fraction had lost at 
least 80% of its neurons compared to the normal 
mean. Fractions which had the most severe neuron loss 
were labeled as the core of the lesion. 
Stage 2b. Lesion border analysis. Once the center of 
the lesion had been located, 8 radial arms were drawn 
using the video image analysis system (JAVA System, 
Jandel, Corp.) emanating from this center along the 
major compass points (0 °, 45 °, 90 °, 135 ° etc., Fig. 1 
lower left). Core sample counts were taken along each 
line at 250 micron steps at 400 × magnification (see 
above) until the neuron density rose above 50% of the 
normal level for that fraction. Lesions borders were 
mapped onto stereotaxic atlas pictures of the represen- 
tative brain slices [63] and were traced into the com- 
puter using a digitizing tablet and a 3-D reconstruction 
program (PC3D, Jandel). The digitized slices were 
converted into a 3-D representation for lesion viewing 
using a lateral, ventral, and a dorsal 3-D view. 
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Stage 3. Subtraction of noncrucial sites of damage. 
A composite map of shared damage was made for each 
syndrome group. This was done by first adding the 
mapped lesions of each rat that showed a particular 
syndrome together. Then any subregion of damage that 
was not shared unanimously by all brains within the 
group was subtracted away in order to eliminate areas 
of damage that were not necessary to produce the 
syndrome. The remaining composite lesion identified 
the common site that was damaged in every rat which 
displayed either hyperkinetic treading plus aversion or 
hyperkinetic treading alone. 
2.8. GFAP-immunoreactivity 
In order to confirm lesion placement by an indepen- 
dent measure, a second technique was employed that 
mapped regions of gliosis based on glial fibrillary acidic 
protein immunoreactivity (GFAP-IR). Glial fibrillary 
acidic protein immunoreactivity preferentially stains 
reactive astrocytes. Free-floating 30 micron sections 
were rinsed in three consecutive washes (PBS with 1% 
bovine serum albumin and 0.03% triton x 100). The 
slices were transferred to 1.5 ml centrifuge tubes con- 
taining rabbit anti-GFAP (primary, diluted 1:500, Dako 
Corp.) and placed on a roto-torque to turn slowly for 
20-24 h at 5°C. The slices were rinsed in three consec- 
utive PBS-BSA (0.03% triton x 100) washes and placed 
into 1.5 ml centrifuge tubes containing peroxidase con- 
jugated to goat anti-rabbit IgG (secondary, diluted 
1:100, Dako Corp.) and rotated for 1 h at room tem- 
perature. The slices were taken through a final set of 
rinses (PBS-BSA + 0.03% triton x 100) followed by an 
8 min bath in freshly prepared 3,3-diaminobenzidine 
tetrahydrochloride on a shaker. The slices were then 
rinsed in distilled water, mounted directly onto a slide 
(gel-coated 2 x ), defatted and coverslipped using per- 
mount. 
Areas of lesion-induced gliosis are much darker 
than the surrounding area after GFAP immunoreactive 
staining. Using a computerized densitometry video 
analysis based on pixel darkness (shades of grey from 
light grey to black) the reactive gliosis was calibrated, 
and a criterion of the darkest 20% of the pixels and the 
darkest 10% of the pixels was set and used to identify 
gliosis shell and core regions respectively. The gliosis 
shell and core were traced on to pictures of brain slices 
[63]. The lateral ventricle and corpus callosum were 
used as landmarks. Maps of lesions constructed by 
gliosis analysis were compared to maps constructed by 
neuronal density analysis. 
2.9. Statistics 
Group averages for taste reactions and paw treading 
duration were compared using the Mann-Whitney U- 
nonparametric test. Mean neuron counts for each stri- 
atopallidal region were compared across groups by a 
two factor (region × treatment group) analysis of vari- 
ance (ANOVA). Differences across regions within le- 
sion groups were analyzed by the a posteriori New- 
man-Keuls test. Means of regional neuron counts be- 
tween lesion groups were also compared using the 
Newman-Keuls test. 
3. Results 
3.1. Behavioral results 
Nine of eleven rats that received bilateral neuro- 
toxin injections into the GP displayed hyperkinetic 
treading to quinine alone (T Syndrome). The average 
treading duration in this group was 14 s per quinine 
taste trial (compared to 0 s for controls, Mann-Whit- 
ney test, P < 0.05, see Fig. 2). No rat in this group 
showed treading to sucrose taste infusions. Taste reac- 
tions (besides exaggerated treading to quinine) did not 
differ from controls, and these rats ate and drank 
normal amounts. 
Eight of twelve rats that received bilateral neuro- 
toxin injections into the ventral pallidum/substantia 
innominata showed hyperkinetic treading to both qui- 
nine and sucrose solutions. These same rats (A + T 
Syndrome) also had a significant increase in the num- 
ber of aversive responses [gapes, head-shakes, fore- 
limb-flails and chin-rubbing] to sucrose (1 M) com- 
pared to sham-injected control rats, which showed 
Q 3O 
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Fig. 2. Duration of hyperkinetic treading to either quinine (Q) or 
sucrose (S) oral infusions by: (1) rats that show the combined 
syndrome of exaggerated treading plus enhanced aversion ( A + T  
Group); (2) rats that showed only the exaggerated treading syndrome 
without enhanced aversive taste reactivity (T Group); 3) rats with 
lesions that did not show either treading or enhanced aversion (N); 
and (4) sham-injected controls (C). * * and * denote significance at 
the P < 0.001 and P < 0.05 levels, respectively. 
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none.  The  average  t r ead ing  du ra t ion  for this g roup  was 
19 s for quin ine  and 16 s for  sucrose ( M a n n - W h i t n e y  
test ,  P < 0.01 c o m p a r e d  to 0 s for  controls ,  see  Fig. 2). 
The  n u m b e r  of  aversive responses  to sucrose was in- 
c reased  to an average  of  13.5 c o m p a r e d  to 0 for  con- 
trois  ( M a n n - W h i t n e y  test ,  P < 0.001). Ra ts  tha t  
showed e n h a n c e d  avers ion plus  hyperk ine t i c  t r ead ing  
(A + T Syndrome)  were  also aphagic  and  adips ic  fol- 
lowing surgery.  The  average  length  of  aphag ia  and 
adips ia  was 5 days ( range,  2 - 7  days for  these  rats).  T h e  
average  weight  loss was 64 g. G e n e r a l  m o t o r  activity 
a p p e a r e d  supp re s sed  and some rats  were  severely  aki- 
A) 
I ....... 50% 
~' 8O% 
. uroo 
' i  
Fig. 3. T Group lesion. Representative lesion mapped to show the result of the fractionator and boundary analysis techniques (A), 
photomicrograph of the globus pailidus from a control rat (10 x magnification, B), and high magnification photomicrograph of the globus 
pallidus from a control rat (40 x ,  C), photomicrograph of lesion from a T Group rat (10 x ,  D) and a high magnification photomicrograph of the 
lesion core from a T Group rat (40 ×,  E). 
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netic with postural deviations such as chronic limb 
extension. 
Rats that received neurotoxin injections into either 
the ventral striatum or into any quadrant of the neos- 
triatum did not show hyperkinetic treading or changes 
in taste reactivity (N Group). 
3.2. Globus pallidus lesions: production of treading alone 
(T syndrome) 
lesion histology was completed 4-14 days post- 
surgery for the T-Group rats. In an analysis to detect 
shrinkage, measurements for striatal or pallidal width 
and length were similar for the T-Group rats and 
controls. This finding suggests that there was minimal 
shrinkage due to excitotoxic injury. Reactive astroglio- 
sis was prominent in the lesion area and most likely 
filled in the regions of neuronal loss. For the T-Group 
rats with neurotoxin injections aimed at the GP that 
displayed hyperkinetic treading to quinine alone, sig- 
nificant bilateral damage compared to sham-injected 
controls was noted in only two regions: the globus 
pallidus and the ventrolateral neostriatum (Three-way 
ANOVA (Group × Region x AP level), F(104, 712) = 
4.806, P<0.001;  globus pallidus and ventrolateral 
neostriatum regions were identified by post-hoc com- 
parisons with control group, P < 0.05, Newman-Keuls). 
Both regions had bilateral damage located at Bregma 
- 0 . 3  mm and - 1.3 mm (globus pallidus > 67% bilat- 
eral damage; ventrolateral neostriatum > 40% neuron 
loss). No other regions distal from the injection site 
had bilateral damage. 
In the more detailed fractionator analysis, a rat-by- 
rat examination was completed for neuron loss within 
the globus pallidus and ventrolateral neostriatum for 
the rats that showed the hyperkinetic treading to qui- 
nine alone. Each rat in this group had damage in a 
subregion of the globus pallidus (Fractions numbers 
208 and 207; Fig. 3). The boundary analysis using 
neuron counts along the 8 radial arms emanating away 
from the center of the lesion for each rat, showed that 
each rat had damage in the ventromedial corner of the 
GP, immediately lateral to the internal capsule and 
dorsal to the VP/SI  region (minimum damage = 60% 
bilateral neuron loss for each rat, see Fig. 4). The 
stereotaxic center for this crucial site, determined by 
subtraction analysis, was located at 1.3 mm posterior 
from bregma (at this AP level each rat had the largest 
lesion area). The lateral diameter of the common site 
was 0.8 mm, the dorsoventral diameter was 1.0 mm and 
the AP diameter was 1.0 mm. 
Surrounding subregions of the GP were damaged in 
only some rats that showed the hyperkinetic treading 
to quinine. Eight out of 9 rats had > 50% damage to 
the overlying dorsal GP and 6 out of 9 rats had > 50% 
neuron loss in the lateral GP. Outside of the GP, the 
Bregma 
-0.3ram 
O - T  SITE 
/GP 
-0.8mm -I .3mm -I .8mm 
Brogma -1.3mm Lateral 2 ,4mm 
T Site 
Fig. 4. Crucial site for the T syndrome as mapped by our modified 
fractionator procedure. The  same views are shown as used in Fig. 6. 
Solid region denotes  site where all rats had at least 60% neuron 
depletion. 
ventrolateral neostriatum was bilaterally damaged in 2 
out of the 9 rats. Ventral to the GP, the VP/SI  or LH 
was bilaterally damaged in only 1 out of 9 rats. GFAP- 
IR had the darkest pattern of staining over the ventro- 
medial GP for each of the rats showing hyperkinetic 
treading to quinine alone. This pattern of results sup- 
ports the idea that damage to the ventromedial GP is 
sufficient to produce the hyperkinetic treading syn- 
drome (T syndrome). 
Significant GP damage was not seen in the non- 
symptomatic rats (n = 2) that received injections aimed 
at the GP. Unilateral damage of the GP was noted in 
both rats. 
3.3. Ventral pallidum /substantia innominata lesions: 
production of treading plus aversion 
Lesion histology for the A + T Group rats was com- 
pleted between 4 and 15 days post-lesion. In an analy- 
sis to detect shrinkage, measurements of striatal and 
pallidal lengths and widths were similar between A + T 
Group rats and sham injected controls. This finding 
suggests that the total volume of the striatopallidal 
region was not significantly different between these 
two groups and that accurate neuronal counts for both 
regional and fractionator analyses could be obtained. 
A + T Group rats had significantly more damage in the 
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VP/SI region at Bregma -1.3 mm compared to both 
control rats and T Group rats (81% average depletion, 
Three-way ANOVA (Group × Region x AP level) 
F(104,712) = 4.806, P < 0.001; ventral pallidal region 
identified by post-hoc comparisons with controls and 
with T Group rats, P < .0.05, Newman-Keuls). Com- 
pared to only sham-injected controls the A + T Group 
rats also had significant bilateral neuron loss in the GP 
(34% neuron depletion, P < 0.05, Newman-Keuls) and 
in the LH (59% neuronal depletion, P < 0.05, New- 
man-Keuls). No other distal regions had bilateral neu- 
ronal damage. 
2 
80% 50% Neuron 
Loss 
c 
Fig. 5. A + T Group lesion. Representative lesion mapped to show the result of the fractionator and boundary analysis techniques (A), control 
photomicrographs of the ventromedial ventral pallidum/substantia innominata (B and C, same magnifications as in Fig. 3), low magnification (D) 
and high magnification (E) of a lesion from a rat in the A + T Group. 







t = A + T  SITE 
-0.Smrn -1.3ram -1 .Smm 
(' -~_ 
" .--- 37x i 
Bregma -1.3mm Lateral 1.9mm A+T Site 
Fig. 6. Crucial site for the A+T syndrome. A 3-dimensional view 
(above) and coronal and sagittal 2-D views (below) of the 'necessary 
and sufficient' site of damage, as mapped by our modified fractiona- 
tor procedure, that produces both hyperkinetic treading and an 
enhancement of aversive reactions to oral infusions. Solid region 
denotes site where all rats had at least 70% neuron depletion. 
Results from the more detailed fractionator analysis 
of striatopallidal subregions showed that common dam- 
age was located only in a subregion of the V P / S I  in 
the A + T Syndrome group (Fraction numbers 215 and 
216; Fig. 5). The lesion boundary analysis using the 8 
radial arms emanating from the lesion center for each 
rat showed that the common subregion within the 
V P / S I  for the group was the ventromedial corner 
which is adjacent to, but outside of, the dorsolateral 
rim of the lateral hypothalamus and ventral and medial 
to the globus pallidus (see Fig. 6). Each rat had at least 
70% neuronal depletion within this area of the VP/SI .  
The center for this common site was 1.3 mm posterior 
from bregma, 2.0 + 0.5 mm lateral from bregma, and 
7.3 + 0.25 mm ventral to the skull as depicted in the 
stereotaxic atlas of Paxinos and Watson, 1986. The 
lateral diameter of the shared lesion site was 1.0 mm, 
the dorsoventral diameter was 0.5 mm and the AP 
diameter was 1.0 mm. 
Subregions outside of the ventromedial V P / S I  were 
damaged in some but not all rats that showed both 
enhanced aversion plus hyperkinetic treading (A + T 
Syndrome). Six out of 8 rats had > 50% neuronal 
depletion bilaterally in the adjacent dorsal ventral pal- 
lidum and 4 out of 8 rats had > 50% bilateral neuron 
loss in the lateral VP/SI .  Outside of the VP/SI ,  the 
GP had > 50% bilateral neuron loss in 5 out of 8 rats, 
and ventrally, the LH had > 50% neuron loss in 4 out 
of 8 rats. No other structure was damaged in at least 4 
of the rats. Dense GFAP-IR was measured over the 
ventromedial V P / S I  in each rat that displayed the 
enhanced aversion plus hyperkinetic treading. These 
results support the conclusion that damage to the 
ventromedial V P / S I  is sufficient to produce these be- 
havioral changes. 
Four rats that received injections aimed into the 
V P / S I  did not show any behavioral changes and even 
though they had some bilateral neuron loss in the 
V P / S I  compared to controls. These 'non-symptomatic' 
rats had much less severe damage compared to 'symp- 
tomatic' rats in the V P / S I  (20-59% neuron loss in the 
non-symptomatic rats compared to a minimum of 70% 
bilateral neuron loss in each symptomatic rat). No 
non-symptomatic rat had bilateral damage exceeding 
70%. This result indicates that a threshold of neuronal 
depletion is necessary for the production of the en- 
hanced aversion and hyperkinetic treading syndrome. 
3. 4. Other lesion groups 
Rats that received injections aimed at the ventral 
striatum had the most damage in this region (>  65% 
bilateral neuron loss). Rats that received neurotoxin 
injections into the different neostriatal quadrants had 
significant bilateral damage in those respective quad- 
rants (dorsolateral neostriatal injection group had > 
69% bilateral neuron loss in the dorsolateral neostria- 
tum; dorsomedial neostriatal injection group had > 
62% bilateral neuron loss in the dorsomedial neostria- 
tum; ventrolateral neostriatal injection group had > 
75% bilateral neuron loss within the ventrolateral 
neostriatum; and ventromedial neostriatum injection 
group had > 81% neuron loss in the ventromedial 
neostriatum). Any extra-striatal damage was seen uni- 
laterally in the striatal lesion groups. 
4. Discussion 
Damage to two neuroanatomically separate sites 
was found to produce the two different behavioral 
syndromes of hyperkinetic treading originally differen- 
tiated by Berridge and Cromwell [11]. Lesions of the 
ventromedial third of the globus pallidus produced the 
sensory-triggered hyperkinetic treading syndrome alone 
(T Syndrome) but did not produce enhanced aversion 
to food (see Fig. 4). This T syndrome site is 1.0 mm by 
0.8 mm by 1.0 mm in diameter and lies just lateral to 
the internal capsule and dorsal to the V P / S I  (Frac- 
tions 207 and 208). Lesions of the ventromedial corner 
of the V P / S I  produced hyperkinetic treading plus an 
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enhancement of aversive taste reactions to oral infu- 
sions (A + T Syndrome; for more discussion of 'aver- 
sion sites' see Cromwell and Berridge [19]). The crucial 
site appears for the A + T syndrome to be 1 mm by 0.5 
mm by 1.0 mm in diameter and is located ventral and 
medial to the globus pallidus and immediately lateral 
to the border of the lateral hypothalamus (Fractions 
215 and 216; Fig. 6). 
The site of  damage (rather than the diameter or the 
suprathreshold severity of a lesion) appears to be the 
primary determinant of which treading syndrome is 
produced. The two sites are approximately 0.5 mm 
apart. Lesions that produce treading plus enhanced 
aversion are ventral and medial to the lesions that 
produce the hyperkinetic treading alone, but they need 
not be larger or more severe than lesions that produce 
the treading syndrome alone. (so long as bilateral dam- 
age in the vmVP/SI, Fractions 215 and 216 in Fig. 3 
exceeds > 60% neuron loss). Interestingly, ventral pal- 
lidal lesions that produce the combined syndrome need 
not damage the globus pallidus 'T Site'. However, 
lesions that do damage both sites always produce the 
combined syndrome of exaggerated treading to both 
sucrose and quinine, as well as aphagia and enhanced 
aversive taste reactions. 
4.1. Ventromedial GP subregion: anatomical connectivity 
The globus pallidus has been divided into ventrome- 
dial and dorsolateral sectors based upon differential 
neuroconnectivity of the sectors with other structures. 
The neostriatum or caudate nucleus and putamen 
(CPU) are the primary afferents to both sectors [38,61]. 
The subthalamic nucleus is the primary efferent [58,59]. 
The ventromedial GP, where lesions produce hyperki- 
netic treading to quinine, receives unique input from 
the ventromedial caudate nucleus and putamen 
(vmCPU) [60,61], which in turn receives its primary 
input from limbic structures: the hippocampus, amyg- 
dala, and cingulate cortex [24,51,61]. The ventromedial 
GP also receives direct input from the nucleus accum- 
bens, which is part of the 'limbic' ventral striatopallidal 
system [43,53]. Injections of the GABA antagonist, 
picrotoxin, into the ventromedial GP abolish hyper- 
locomotion initiated by stimulation of the nucleus ac- 
cumbens [43]. This direct influence of the ventral stria- 
tum upon the ventromedial globus pallidus has been 
argued to provide "a direct link between limbic and 
motor systems for the translation of motivation into 
action." (Jones and Mogenson, [43] p. 104.) 
4. 2. Ventromedial VP / SI subregion: anatomical connec- 
tivity 
Both the A + T and T hyperkinetic syndromes have 
been shown to involve an interaction of sensorimotor 
and motivational (aversion) processes [11]. The T Syn- 
drome is activated by naturally aversive stimuli, such as 
quinine, whereas the A + T Syndrome causes all tastes 
to be reacted to as aversive. Both the ventromedial 
VP/SI and the ventromedial GP have iimbic neu- 
roanatomical connections that make them distinctively 
different from dorsolateral subregions of the VP and 
GP [34-37,40,55,79]. Several researchers have sug- 
gested that the ventromedial subregions of the ventral 
pallidum/substantia innominata and globus pallidus 
have a special role in motivational and motor interac- 
tion [5,53,62,79]. 
The ventromedial VP/SI has a set of distinct con- 
nections, which for the most part are different from 
those of the dorsolateral VP/SI [29,30,39,78]. Specifi- 
cally, the ventromedial VP/SI [28] receives input from 
the shell portion of the nucleus accumbens [41,78], the 
medial part of the bed nucleus of the stria terminalis 
(mBNST), the medial nucleus of the central amygdala 
(ceAM), the medial preoptic nucleus (MPO), the ante- 
rior hypothalamus (allY), the medial area of the lat- 
eral hypothalamus (LH) and the ventromedial hypo- 
thalamus (VMH) [32]. This input to the ventromedial 
VP/SI from various limbic structures has reinforced 
the idea that ventral striatopallidal efferents partici- 
pate in motivational processing [5,39,60]. 
The ventromedial VP/SI sends reciprocal connec- 
tions back to the mBNST, ceAM, MPO, ally, and LH 
[9,31]. Efferent projections also extend to the peduncu- 
lopontine nucleus (PPnT), the cortex, and the ventral 
tegmental area (VTA) [36,76,77]. Several researchers 
have proposed that the VP projections to either cortex 
or to the PPnT could allow access to sensorimotor 
processes [36,54,56]. The VP to PPnt connection has 
been shown to influence locomotion by experiments 
that used both electrophysiological and pharmacologi- 
cal techniques [52,54,55]. The ventral pallidal projec- 
tion to the VTA region may also influence motor 
circuitry by modulating the dopamine neurons that 
project to the 'motor' dorsal striatum [30]. This ventral 
to dorsal striatopallidal connection through the mid- 
brain could be important in integrating motivational 
and motor processes. 
4.3. Neuropathological models and clinical perspectives 
Recent models of hyperkinetic movements in hu- 
mans postulates that disinhibition of the lateral globus 
pallidus (LGP) by degenerative striatal disease is the 
cause of the hyperkinetic movements of certain disor- 
ders [1,21,23,64,75]. Disinhibition of the LGP [3,4] is 
hypothesized by these models to be a result of a 
selective early degeneration of the co-localized 
GABA/ENK inhibitory striatopallidal projection. The 
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early loss of this projection [2] is consistent with post- 
mortem studies of brains of patients with Huntington's 
disease [65]. Since the LGP is thought to normally 
inhibit the subthalamic nucleus (STN), then, "the ulti- 
mate effect would be loss of the STN-derived excita- 
tory drive to the MGP and SNr and disinhibition of the 
V A / V L / M D / C M - p f  thalamocortical projection." 
(Albin et. al., [1] p. 370), resulting in hyper-excitation 
of the motor cortical areas and hyperkinesis. 
Based upon these models, it could be predicted that 
pallidal destruction should lead to hypokinesis. The 
results of our lesion analysis, however, show that dam- 
age to the ventral pallidum/substantia innominata and 
globus pallidus can produce hyperkinetic treading 
movements triggered by oral sensory stimulation. Sev- 
eral factors could lead to this discrepancy between our 
results and the predictions made by these models of 
hyperkinetic disorders. The time progression and the 
selectivity [74] of neuropathology may be important in 
producing the differences between our results and the 
model's predictions. Human disorders usually are 
chronic diseases characterized by degeneration of a 
gradual nature. In contrast, our pathology was caused 
by an acute injection of excitotoxin that produced rapid 
onset of hyperkinetic symptoms. Acute injections of 
neurotoxic quinolinic acid appear to cause non-selec- 
tive striatal neuron 10ss [12] (although this point is still 
controversial) [8]. More realistic techniques for mimick- 
ing Huntington's disease neuropathology have recently 
been devised, which use chronic injections (3-7 weeks) 
of smaller amounts of quinolinic acid [7,72]. For exam- 
ple, Bazzett and colleagues have found selective neu- 
ronal degeneration patterns within the dorsal stri- 
atopallidal system of rats after a chronic infusion of 
minute amounts of quinolinic acid (3.3 ~moles), not 
unlike that found in the post-mortem brain of a Hunt- 
ington's disease patient [7]. A better test of the hyper- 
kinetic disorder model [1,20,64,66,75], would be to 
combine chronic excitotoxin infusions into the striatum 
or globus pallidus with our behavioral test of sensory- 
triggered hyperkinetic treading. 
In any case, our results indicate that hyperkinetic 
movements can be elicited from rats after pallidal 
damage. Could damage to the pallidal region be in- 
volved in human hyperkinetic disorders? Lange and 
colleagues found that the volume of the lateral globus 
pallidus was reduced in Huntington's chorea as much 
as the caudate nucleus and putamen (57% globus palli- 
dal reduction compared to 56% striatal reduction) [47] 
This finding prompted Lange et.al, to note that, "In 
Huntington's chorea the pallidum was more severely 
affected than is commonly appreciated." (Lange et al., 
[47] p. 401). 
Do hyperkinetic symptoms ever occur following le- 
sions to the pallidal region without striatal damage in 
humans, as would be predicted from our observations 
in rats? Hyperkinetic symptoms have been reported in 
a number of human patients who have suffered acute 
damage to the region of the globus pallidus. For exam- 
ple, buccofacial dyskinesia and truncal choreic move- 
ments have been seen after specific bilateral damage to 
the GP in humans following carbon monoxide poison- 
ing or hemorrhage involving this region bilaterally 
[48,69]. Specific hyperkinetic movements include face 
and jaw movements that resemble tics, and involuntary 
finger movements during 'mental counting'. The walk- 
ing gait of such a patient was described as choreic in 
nature [48]. These motor symptoms are accompanied 
by drastic changes in motivation and cognition [48,69] 
which may be related to the motivational changes 
produced by our lesions [11] 
5. Conclusions 
In summary, this study mapped the location of two 
sites where neuron death produces two distinct sen- 
sory-triggered hyperkinetic syndromes. Damage to a 
site in the ventromedial globus pallidus (Fractions 207 
and 208), exceeding a threshold of 60% bilateral neu- 
ron loss, produced the sensory-triggered treading syn- 
drome but did not produce an increase in aversive 
taste reactions. The T syndrome site was approximately 
0.8 mm × 1.0 mm × 1.0 mm in diameter. Damage to a 
ventromedial VP/SI site, exceeding 70% bilateral neu- 
ron loss, produced a combined syndrome of hyperki- 
netic treading and enhanced taste aversion to sensory 
triggers. The A + T syndrome site occupied the ventro- 
medial corner of the ventral pallidum/substantia in- 
nominata (Fractions 215 and 216) and was ascertained 
to be approximately 1.0 mm × 0.5 mm × 1.0 mm in 
diameter (height, width, length). The determinant of 
which hyperkinetic syndrome was shown by an individ- 
ual rat was found to be due to the placement of the 
lesion relative to these sites, rather than to the size or 
the suprathreshold severity of the excitotoxin lesions. 
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